Drug Pipeline & Clinical Insights – October 2026
This month’s Drug Pipeline & Clinical Insights explores three new specialty therapies and what they could mean for pharmacy benefits, including cost, access, and appropriate use.
This month’s Drug Pipeline & Clinical Insights explores three new specialty therapies and what they could mean for pharmacy benefits, including cost, access, and appropriate use.
Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.
Understand why specialty drug access breaks down after coverage is approved and how employers can close the gap between coverage and care.